AAMC Altisource Asset Management Corp gains 58% Feb 28, 2020

Altisource Asset Management Corporation, an asset management company, provides portfolio management and corporate governance services to institutional investors in the United States. The company offers its services under an asset management agreement to Altisource Residential Corporation, which acquires and manages single-family rental properties for working class families. It also provides management services to NewSource Reinsurance Company Ltd. The company was founded in 2012 and is headquartered in Christiansted, Virgin Islands.http://www.priceseries.com/trade/AAMC-Altisource-Asset-Management-Corp-stock-gains-58-percent-a-Trade-Record-by-priceSeries-2020021420200228.html

SQNS Sequans Communications S.A. gains 17% Feb 26, 2020

Sequans Communications S.A., together with its subsidiaries, engages in fabless designing, developing, and supplying 4G LTE semiconductor solutions for wireless broadband applications. Its solutions incorporate baseband processor and radio frequency (RF) transceiver integrated circuits along with proprietary signal processing techniques, algorithms, and software stacks. The company offers baseband solutions used to encode and decode data based on 4G protocols that serve as the wireless processing platform for a 4G device; RF transceivers used to transmit and receive wireless transmissions; and system-on-chip solutions that integrate the baseband and RF transceiver functions. Its solutions serves as the wireless broadband communications platform in various devices, including smartphones; USB dongles; portable routers; embedded wireless modems for laptops, tablets, and other consumer multimedia devices; and customer-premises equipment, such as fixed wireless access modems, routers, and residential gateways. The company serves OEMs, ODMs, contract manufacturers, or system integrators, as well as distributors who provide customer communications, logistics, and support functions. It operates in Europe, the Middle East, Africa, the Americas, and Asia. Sequans Communications S.A. was founded in 2003 and is headquartered in Paris, France.http://www.priceseries.com/trade/SQNS-Sequans-Communications-SA-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020021220200226.html

MLSS Milestone Scientific, Inc. gains 19% Feb 26, 2020

Milestone Scientific Inc. provides technologies and solutions for the medical and dental markets in the United States, Canada, Asia, Africa, South America, and Europe. The company's products include STA Single Tooth Anesthesia Instrument, a computer-controlled local anesthesia delivery instrument that incorporates the pressure feedback elements of its patented CompuFlo technology, which allows dentists to administer injections into the periodontal ligament space; and CompuDent, a computer-controlled local anesthetic delivery instrument that provides painless injections for various routine dental treatments, including root canals, crowns, fillings, and cleanings. Its products also comprise CompuMed, a computer-controlled injection instrument for use in various applications, such as colorectal surgery, podiatry, dermatology, cosmetic surgery, hair restoration surgery, nasal and sinus surgery, orthopedics, and others. In addition, the company provides The Wand, a hand piece that allows bi-directional rotation during injection, which prevents needle deflection that occurs with a traditional syringe. Milestone Scientific Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.http://www.priceseries.com/trade/MLSS-Milestone-Scientific-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2020021220200226.html

CFRX ContraFect Corp. gains 23% Feb 26, 2020

ContraFect Corporation, a clinical-stage biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases in the United States. Its lead product candidates consist of CF-301, a lysin that completed Phase 1 human clinical trials for the treatment of Staph aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible Staph aureus; and CF-404, a combination of human monoclonal antibodies (mAbs) for the treatment of life-threatening seasonal and pandemic varieties of human influenza. The company has a collaboration research agreement with The Rockefeller University to identify new lysin therapeutic candidates targeting Gram-negative bacteria; and license agreement with Trellis Bioscience LLC for mAbs in the field of influenza. ContraFect Corporation was founded in 2008 and is headquartered in Yonkers, New York.http://www.priceseries.com/trade/CFRX-ContraFect-Corp-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2020021320200226.html

CC Chemours Company (The) gains 17% Feb 25, 2020

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide (TiO2) under the Ti-Pure brand name to deliver whiteness, brightness, opacity, and protection in various applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, PVC window profiles, laminate papers, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, industrial fluoropolymer resins, coatings, and other downstream products under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals used in gold production, oil refining, agriculture, industrial polymers, and other industries. This segment provides mining solutions; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.http://www.priceseries.com/trade/CC-Chemours-Company-The-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020021120200225.html

XLRN Acceleron Pharma Inc. gains 15% Feb 24, 2020

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for serious and rare diseases. Its therapeutic candidates include luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassemia; and sotatercept for chronic kidney diseases. The company's therapeutic candidates also include Dalantercept, a tyrosine kinase inhibitor, which is in phase II clinical trials for renal cell carcinoma; and ACE-083 that is in phase II clinical trials for facioscapulohumeral dystrophy. It has collaboration, license, and option agreement with Celgene Corporation. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/XLRN-Acceleron-Pharma-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020012820200224.html

VSLR Vivint Solar, Inc. gains 22% Feb 24, 2020

Vivint Solar, Inc. provides distributed solar energy to residential, commercial, and industrial customers in the United States. It operates through two segments, Residential, and Commercial and Industrial. The company installs and owns solar energy systems through long-term customer contracts. It also offers photovoltaic installation devices and software products. As of December 31, 2016, the company had an aggregate capacity of 681.1 megawatts covering 99,600 homes in 14 states. It has operations in Arizona, California, Connecticut, Florida, Hawaii, Maryland, Massachusetts, New Jersey, New Mexico, New York, Pennsylvania, South Carolina, Texas, and Utah. The company was formerly known as V Solar Holdings, Inc. and changed its name to Vivint Solar, Inc. in April 2014. Vivint Solar, Inc. was founded in 2011 and is headquartered in Lehi, Utah.http://www.priceseries.com/trade/VSLR-Vivint-Solar-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2020020520200224.html

UIS Unisys Corp. gains 47% Feb 24, 2020

Unisys Corporation provides information technology services worldwide. It operates through two segments, Services and Technology. The Services segment provides cloud and infrastructure services, application services, and business process outsourcing services. The Technology segment designs and develops software, servers, and related products. It offers a range of data center, infrastructure management, and cloud computing offerings for clients to virtualize and automate data-center environments. This segment's product offerings include ClearPath Forward operating system software for high-volume enterprise computing; Unisys Stealth software to protect data in data centers, the cloud, and mobile infrastructures; Digital Investigator, a browser-based application for total information management; AirCore solution that enables airlines to reach passenger through mobile, tablet, and web; and Unisys Retail Delivery, which is an integrated and multi-channel retail banking system. The company serves customers in the government, commercial, and financial services markets through direct sales force, distributors, resellers, and alliance partners. Unisys Corporation was founded in 1886 and is based in Blue Bell, Pennsylvania.http://www.priceseries.com/trade/UIS-Unisys-Corp-stock-gains-47-percent-a-Trade-Record-by-priceSeries-2020020520200224.html

TSRI TSR, Inc. gains 24% Feb 21, 2020

TSR, Inc. provides contract computer programming services in the New York metropolitan area, New England, and the Mid-Atlantic region. It offers technical computer personnel to supplement the in-house information technology capabilities of its customers in the areas of mainframe and mid-range computer operations, personal computers and client-server support, Internet and e-commerce operations, and help desk support, as well as voice and data communications, including local and wide area networks. The company primarily serves vendor management companies, as well as customers in the financial services business. TSR, Inc. was founded in 1969 and is based in Hauppauge, New York.http://www.priceseries.com/trade/TSRI-TSR-Inc-stock-gains-24-percent-a-Trade-Record-by-priceSeries-2020022020200221.html

TNDM Tandem Diabetes Care, Inc. gains 18% Feb 24, 2020

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its disposable insulin cartridge, and an infusion set. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; and t:slim G4 insulin delivery system, a touch-screen pump with an integrated CGM system. In addition, the company offers Tandem Device Updater, a PC and Mac-compatible Web-based system that allows users to update their pump's software; t:connect diabetes management application, a cloud-based data management application, which provides a visual way to display therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers; t:90 and t:30 infusion sets for use with its insulin pump products; and various pump accessories. Its products in development include t:slim X2 with G5 integration; automated insulin delivery systems; t:slim X2 with PLGS; t:slim X2 with TypeZero; and t:sport insulin delivery system. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.http://www.priceseries.com/trade/TNDM-Tandem-Diabetes-Care-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2020012820200224.html

TERP TerraForm Power, Inc. gains 32% Feb 24, 2020

TerraForm Power, Inc. owns and operates solar and wind generation assets serving utility, commercial, and residential customers. As of October 31, 2016, its portfolio consisted of solar and wind projects located in the United States, Canada, the United Kingdom, and Chile with an aggregate nameplate capacity of 2,986.9 megawatts. The company was formerly known as SunEdison Yieldco, Inc. and changed its name to TerraForm Power, Inc. in May 2014. The company was founded in 2014 and is headquartered in Bethesda, Maryland. TerraForm Power, Inc. is a former subsidiary of SunEdison Holdings Corporation.http://www.priceseries.com/trade/TERP-TerraForm-Power-Inc-stock-gains-32-percent-a-Trade-Record-by-priceSeries-2020010920200224.html

SQ Square, Inc. gains 18% Feb 24, 2020

Mobile payment service provider for small businesses.http://www.priceseries.com/trade/SQ-Square-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2020010720200224.html

SLM SLM Corp. gains 29% Feb 24, 2020

SLM Corporation, together with its subsidiaries, operates as a saving, planning, and paying for college company in the United States. It offers private education loans to students and their families. The company also provides banking products, such as certificates of deposits, money market deposit accounts, and high yield savings accounts; and a consumer savings network that offers financial rewards on everyday purchases to help families save for college. SLM Corporation was founded in 1972 and is headquartered in Newark, Delaware.http://www.priceseries.com/trade/SLM-SLM-Corp-stock-gains-29-percent-a-Trade-Record-by-priceSeries-2020012220200224.html

RUN Sunrun Inc. gains 19% Feb 24, 2020

Sunrun Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. It also sells solar leads. The company markets and sells its products through direct channels, partner channels, mass media, digital media, canvassing, referral, retail, and field marketing. Sunrun Inc. was founded in 2007 and is headquartered in San Francisco, California.http://www.priceseries.com/trade/RUN-Sunrun-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2020020320200224.html

RNG Ringcentral, Inc. gains 27% Feb 24, 2020

RingCentral, Inc. provides software-as-a-service solutions for business communications in the United States and internationally. The company's products include RingCentral Office, a multi-tenant, multi-location, enterprise-grade communications solution that enables employees to communicate through voice, text, team messaging and collaboration, and HD video and Web conferencing, including smartphones, tablets, PCs, and desk phones for businesses that require a communications solution; RingCentral Professional, an inbound call routing subscription with text and fax capabilities primarily for smaller businesses; and RingCentral Fax solution that provides Internet fax capabilities, which allow businesses to send and receive fax documents without the need for a fax machine. Its products also comprise RingCentral Contact Center, which provides a cloud based contact center solution that delivers multi-channel capabilities; and RingCentral Glip, a team messaging and collaboration solution that allows a range of teams to stay connected through various modes of communication through an integration with RingCentral Office. The company serves advertising, healthcare, real estate, retail, technology, insurance, education, waste management, construction, restaurant, software, solar, automotive dealership, managed care, and publishing industries; and financial, legal, and security service providers, as well as non-profit organizations through its direct sales representatives and resellers. RingCentral, Inc. was founded in 1999 and is headquartered in Belmont, California.http://www.priceseries.com/trade/RNG-Ringcentral-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2020010820200224.html

PODD Insulet Corp. gains 16% Feb 24, 2020

Insulet Corporation, a medical device company, develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of the OmniPod, an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.http://www.priceseries.com/trade/PODD-Insulet-Corp-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020010820200224.html

PENN Penn National Gaming, Inc. gains 37% Feb 24, 2020

Penn National Gaming, Inc. owns and manages gaming and racing facilities, and operates video gaming terminals with a focus on slot machine entertainment. The company operates through Northeast, South/West, and Midwest segments. As of December 31, 2016, it operated 27 facilities in 17 jurisdictions, including California, Florida, Illinois, Indiana, Kansas, Maine, Massachusetts, Mississippi, Missouri, Nevada, New Jersey, New Mexico, Ohio, Pennsylvania, Texas, West Virginia, and Ontario, Canada. It operated approximately 35,000 gaming machines, 800 table games, and 4,600 hotel rooms. The company was formerly known as PNRC Corp. and changed its name to Penn National Gaming, Inc. in 1994. Penn National Gaming, Inc. was founded in 1972 and is based in Wyomissing, Pennsylvania.http://www.priceseries.com/trade/PENN-Penn-National-Gaming-Inc-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2020012820200224.html

PCOM Points Intl., Ltd. gains 16% Feb 24, 2020

Points International Ltd. provides Web-based solutions to the loyalty program industry primarily in the United States, Europe, and Canada. It provides various white label or private branded ecommerce services, such as the online sale of loyalty currency direct to program members in order for the members to top-up their accounts to reach a redemption threshold or as a gift for friends and family members; and the online transfer of pre-existing loyalty currency from one member into another member's account, primarily a family member or friend, as another means of enabling that other member to accumulate sufficient miles or points to reach a redemption threshold. The company's services enable the sale of loyalty currencies, such as frequent flyer miles, hotel points, and credit card points, as well as enhance loyalty program consumer offerings and their back end operations. It also operates Points.com, a consumer focused reward management Website that provides members of multiple loyalty programs the ability to track and manage their loyalty currencies, including their financial assets. The company was incorporated in 1999 and is headquartered in Toronto, Canada.http://www.priceseries.com/trade/PCOM-Points-Intl-Ltd-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020012220200224.html

PBYI Puma Biotechnology Inc gains 17% Feb 24, 2020

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care. Its drug candidates include PB272 (neratinib (oral)) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 (neratinib (intravenous)). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.http://www.priceseries.com/trade/PBYI-Puma-Biotechnology-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020020420200224.html

OCUL Ocular Therapeutix, Inc. gains 16% Feb 24, 2020

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology in the United States. It markets ReSure Sealant, a hydrogel-based ophthalmic wound sealant to seal corneal incisions following cataract surgery. The company's lead product includes DEXTENZA, which is in Phase III clinical trial for the treatment of post-surgical pain and inflammation, allergic conjunctivitis; and in Phase II clinical trial for the treatment of inflammatory dry eye disease. It is also developing OTX-TP, which is in Phase III clinical trial for glaucoma and ocular hypertension. In addition, the company has preclinical development of intravitreal depot with protein-based or small molecule drugs, including tyrosine kinase inhibitors, for the treatment of wet age-related macular degeneration and other retinal diseases. It has a strategic collaboration, option, and license agreement with Regeneron Pharmaceuticals, Inc. for the development of sustained release formulation of the vascular endothelial growth factor trap aflibercept for the treatment of wet age-related macular degeneration and other serious retinal diseases. Ocular Therapeutix, Inc. was founded in 2006 and is headquartered in Bedford, Massachusetts.http://www.priceseries.com/trade/OCUL-Ocular-Therapeutix-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020020320200224.html

NUAN Nuance Communications, Inc. gains 15% Feb 24, 2020

Nuance Communications, Inc. provides voice recognition and natural language understanding solutions worldwide. It operates through four segments: Healthcare, Mobile, Enterprise, and Imaging. The Healthcare segment offers transcription solutions, which enables physicians to streamline clinical documentation with medical transcription platform; Dragon Medical, a dictation software that empowers physicians to accurately capture and document patient care in real-time on various devices; clinical document improvement and coding solutions to ensure patient health information is accurately documented, coded, and evaluated; and diagnostic solutions that allows radiologists to document, collaborate, and share medical images and reports. It also provides Dragon professional and personal productivity solutions to business users and consumers. The Mobile segment provides a portfolio of virtual assistants and connected services built on voice recognition, text-to-speech, natural language understanding, dialog, and text input technologies to automotive manufacturers, device makers, and mobile operators. The Enterprise segment offers OnPremise solutions and services, an automated customer service solution comprising speech recognition, voice biometrics, transcription, text-to-speech, and dialog and analytics products; and OnDemand multichannel cloud, a platform that offers enterprises the ability to implement automatic customer service. The Imaging segment provides MFP Scan automation solutions to offer scanning and document management solutions; MFP Print automation solutions to deliver printing and document management solutions; and PDF and OCR software, a technology that enables the capture, creation, and management of document workflows. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was founded in 1992 and is headquartered in Burlington, Massachusetts.http://www.priceseries.com/trade/NUAN-Nuance-Communications-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020020420200224.html

MTBC Medical Transcription Billing, Corp. gains 18% Feb 24, 2020

Medical Transcription Billing, Corp., a healthcare information technology company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. It primarily offers PracticePro, a Web-based software-as-a-service platform, which includes practice management solutions and related tools, which facilitate the day-to-day operation of a medical practice; electronic health record (EHR) solutions that enables customers to reduce paperwork and qualify for government incentives; revenue cycle management services, such as end-to-end medical billing, analytics, and related services; and mobile health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The company also provides ChartsPro, a Web-based EHR solution; transcription, coding, indexing, and other ancillary services; clearinghouse services, which enables clients to track claim status; batch electronic claim and payment transaction clearing services; and electronic data interchange management system that audits, manages, and controls the exchange of information. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinical staff that render bills for their services. The company was founded in 1999 and is headquartered in Somerset, New Jersey.http://www.priceseries.com/trade/MTBC-Medical-Transcription-Billing-Corp-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2020020620200224.html

MBUU Malibu Boats, Inc. gains 16% Feb 24, 2020

Malibu Boats, Inc. designs, manufactures, markets, distributes, and sells sport boats. The company provides boats for use in water sports, including water skiing, wakeboarding, and wake surfing, as well as general recreational boating. It also offers various accessories and aftermarket parts. The company sells its performance boats under the Malibu and Axis brands through a network of independent dealers in North America, South America, Europe, Asia, Australia, and New Zealand markets. Malibu Boats, Inc. was founded in 1982 and is based in Loudon, Tennessee.http://www.priceseries.com/trade/MBUU-Malibu-Boats-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020011520200224.html

JKS JinkoSolar Holding Company Ltd. gains 23% Feb 24, 2020

JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the design, development, production, and marketing of photovoltaic products in the People's Republic of China and internationally. It offers solar modules, solar cells, silicon ingots, silicon wafers, and recovered silicon materials. The company sells its products to distributors, project developers, and system integrators under the JinkoSolar brand, as well as on an original equipment manufacturer basis. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People's Republic of China.http://www.priceseries.com/trade/JKS-JinkoSolar-Holding-Company-Ltd-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2020020420200224.html

INFU InfuSystems Holdings, Inc. gains 22% Feb 24, 2020

InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, hospital outpatient, and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. It delivers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.http://www.priceseries.com/trade/INFU-InfuSystems-Holdings-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2020020320200224.html

HIMX Himax Technologies, Inc. gains 19% Feb 24, 2020

Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies to consumer electronics worldwide. The company operates through Driver IC and Non-Driver Products segments. It offers display driver integrated circuits (ICs) and timing controllers used in televisions (TVs), laptops, monitors, mobile phones, tablets, digital cameras, car navigation, and other consumer electronics devices. The company also designs and provides controllers for touch sensor displays, liquid crystal on silicon micro-displays used in palm-size projectors and head-mounted displays, light-emitting diode driver ICs, power management ICs, scaler products for monitors and projectors, tailor-made video processing IC solutions, and silicon IPs. In addition, it offers digital camera solutions, including complementary metal oxide semiconductor image sensors and wafer level optics, which are used in various applications, such as mobile phone, tablet, laptop, TV, PC camera, automobile, security, and medical devices. The company markets its products to panel manufacturers, agents or distributors, module manufacturers, and assembly houses; and camera module manufacturers, optical engine manufacturers, and television system manufacturers. Himax Technologies, Inc. was founded in 2001 and headquartered in Tainan City, Taiwan.http://www.priceseries.com/trade/HIMX-Himax-Technologies-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2020013020200224.html

HIIQ Health Insurance Innovations, Inc. gains 17% Feb 24, 2020

Health Insurance Innovations, Inc. operates as a developer, distributor, and administrator of cloud-based individual health and family insurance plans, and supplemental products in the United States. The company offers short-term medical plans that cover individuals for up to 364 days with various deductible and copay levels; hospital indemnity plans, which provide daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products comprising pharmacy benefit cards, dental plans, vision plans, and cancer/critical illness plans, as well as deductible and gap protection plans, and life insurance policies. It designs and structures individual health and family insurance plans, and supplemental products on behalf of insurance carriers and discount benefit providers; and market them to individuals through a network of distributors. Health Insurance Innovations, Inc. was founded in 2008 and is based in Tampa, Florida.http://www.priceseries.com/trade/HIIQ-Health-Insurance-Innovations-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020020320200224.html

HCHC HC2 Holdings, Inc. gains 58% Feb 24, 2020

HC2 Holdings, Inc. engages in construction, marine services, insurance, telecommunications, energy, life sciences, and other businesses in the United States, the United Kingdom, and internationally. The company fabricates and erects structural steel for commercial and industrial construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, and power plants. It also fabricates trusses and girders; and fabricates and erects water pipes, water storage tanks, pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators, and various customized products. In addition, the company provides subsea cable installation and maintenance services for the telecommunications sector; installation, maintenance, and repair services for fiber optic communication and power infrastructure to offshore platforms; and installation services for power cables for use in offshore wind farms and in the offshore wind market. Further, it distributes natural gas motor fuels; designs, builds, owns, acquires, operates, and maintains compressed natural gas fueling stations for transportation vehicles; and offers voice communication services for national telecommunications, mobile, prepaid, and voice over Internet protocol service operators, as well as wholesale carriers and Internet service providers. Additionally, the company provides long-term care, life, and annuity insurance products to individuals. Furthermore, it focuses on developing products to treat early osteoarthritis of the knee; develops skin lightening technology; owns licenses to create and distribute NASCAR video games; and offers analytics on broadcast TV, digital, and social media online platforms. The company was formerly known as PTGi Holding Inc. and changed its name to HC2 Holdings, Inc. in April 2014. HC2 Holdings, Inc. was founded in 1994 and is headquartered in New York, New York.http://www.priceseries.com/trade/HCHC-HC2-Holdings-Inc-stock-gains-58-percent-a-Trade-Record-by-priceSeries-2020012720200224.html

FLGT Fulgent Genetics Inc gains 23% Feb 24, 2020

N/Ahttp://www.priceseries.com/trade/FLGT-Fulgent-Genetics-Inc-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2020020420200224.html

ELF ELF Beauty Inc gains 17% Feb 24, 2020

e.l.f. Beauty Inc is a cosmetic company. The Company along with its subsidiaries conduct business under the name e.I.f. Cosmetics, offering products for eyes, lips, and face to consumers through its retail customers, e.I.f. stores and e-commerce channels.http://www.priceseries.com/trade/ELF-ELF-Beauty-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020013120200224.html

CPRX Catalyst Pharmaceuticals, Inc. gains 15% Feb 24, 2020

Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which is in second Phase III clinical trials for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as well as is in Phase II/III clinical trial for the treatment of anti-MuSK antibody positive myasthenia gravis. The company also develops CPP-115, a gamma-aminobutyric acid aminotransferase inhibitor that is in Phase Ib clinical trial for the treatment of epilepsy, infantile spams, and Tourette's disorder; and CPP-109 to treat Tourette's disorder. It has a strategic collaboration with BioMarin Pharmaceutical Inc. for the development of Firdapse. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.http://www.priceseries.com/trade/CPRX-Catalyst-Pharmaceuticals-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020020420200224.html

CGEN Compugen Ltd. gains 40% Feb 24, 2020

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company's pipeline primarily includes early and preclinical stage immuno-oncology programs based on novel drug targets, such as immune checkpoint and myeloid protein target candidates to harness the immune system to provide treatment solutions in the areas of unmet medical needs in various cancer types and patient populations. Its antibody drug conjugate target candidates comprise CGEN-15001T, CGEN-15022, CGEN-15029, and CGEN-15137 for oncology; and therapeutic proteins include CGEN-15001, a fusion protein for autoimmune diseases, as well as CGEN myeloid target. The company was incorporated in 1993 and is headquartered in Holon, Israel.http://www.priceseries.com/trade/CGEN-Compugen-Ltd-stock-gains-40-percent-a-Trade-Record-by-priceSeries-2020012320200224.html

CALX Calix, Inc gains 20% Feb 24, 2020

Calix, Inc., together with its subsidiaries, develops, markets, and sells broadband communications access platforms, systems, and software for fiber- and copper-based network architectures that enable communications service providers (CSPs) to transform networks and connect to residential and business subscribers. The company develops and sells carrier-class hardware and cloud products to enhance and transform CSP access networks to meet the demands of subscribers. Its portfolio consists of three core systems and/or nodes: E-Series access systems and nodes, B6 access nodes, and the C7 multiservice, multiprotocol access system. The company also offers the P-Series optical network terminals and residential gateways; the GigaFamily of GigaCenters, GigaHubs, and GigaPoints; and the Calix Management System, OpenLink cable software, and Compass Cloud family of software-as-a-service products. Its portfolio serves the CSP network from the central office or data center to the subscriber premises and enables CSPs to deliver voice, high-speed data, and broadband services over legacy and next-generation access networks. The company markets its access systems and software to CSPs in the United States, the Caribbean, Canada, Europe, and internationally through its direct sales force and resellers. Calix, Inc. was founded in 1999 and is headquartered in Petaluma, California.http://www.priceseries.com/trade/CALX-Calix-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2020011520200224.html

BRO Brown & Brown, Inc. gains 16% Feb 24, 2020

Brown & Brown, Inc. markets and sells insurance products and services primarily in the United States, as well as in England, Bermuda, and the Cayman Islands. Its Retail segment provides property insurance relating to physical damage to property and resultant interruption of business, or extra expense caused by fire, windstorm, or other perils; casualty insurance; fidelity and surety bonds; and life, accident, disability, health, hospitalization, medical, dental, and other ancillary insurance products, as well as risk management and loss control surveys and analysis, consultation, and claims processing services. The company's National Programs segment offers professional liability and related package insurance products for professional groups comprising dentists, oral surgeons, hygienists, lawyers, certified public accountants, optometrists, opticians, ophthalmologists, insurance agents, financial advisors, registered representatives, securities broker-dealers, benefit administrators, real estate brokers, real estate title agents, and escrow agents, as well as supplementary insurance products related to weddings, events, medical facilities, and cyber liabilities. This segment also provides outsourced product development, marketing, underwriting, actuarial, compliance, and claims and other administrative services to insurance carrier partners; and commercial and public entity-related programs, as well as underwrites flood insurance products. Its Wholesale Brokerage segment markets and sells excess and surplus commercial insurance products and services to retail insurance agencies. The company's Services segment offers third-party claims administration and medical utilization management services in the workers' compensation and all-lines liability arenas, as well as Medicare set-aside, Social Security disability, and Medicare benefits advocacy services, and claims adjusting services. The company was founded in 1939 and is headquartered in Daytona Beach, Florida.http://www.priceseries.com/trade/BRO-Brown-&-Brown-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020011520200224.html

BIIB Biogen Inc. gains 15% Feb 24, 2020

Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA to treat multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and other potential anti-CD20 therapies. The company's Phase III clinical trial products comprise GAZYVA for the treatment of front-line indolent non-hodgkin's lymphoma; and Aducanumab and E2609 for Alzheimer's disease. Its Phase II clinical trial products include BIIB074 for trigeminal neuralgia, lumbosacral radiculopathy, and erythromelalgia; BAN2401 for Alzheimer's disease; Opicinumab (anti-LINGO-1) for MS; TYSABRI for acute ischemic stroke; rAAV-XLRS for X-linked juvenile retinoschisis; BG00011 (STX-100) for idiopathic pulmonary fibrosis; and Dapirolizumab pegol and BIIB059 (Anti-BDCA02) for lupus. The company's Phase I clinical trial products comprise BIIB061 for MS; BIIB054 for Parkinson's disease; BIIB067 (IONIS-SOD1Rx) for amyotrophic lateral sclerosis; and BIIB068 (BTK Inhibitor) for autoimmune disease. It has collaboration agreements with AbbVie, Inc.; Acorda Therapeutics, Inc.; Applied Genetic Technologies Corporation; Eisai Co., Ltd.; Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and University of Pennsylvania. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/BIIB-Biogen-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020020420200224.html

AVXL Anavex Life Sciences Corp. gains 41% Feb 24, 2020

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimer's disease, other central nervous system diseases, pain, and various cancers. The company's lead drug candidates include ANAVEX 2-73, a Phase 2a clinical trial for the treatment of Alzheimer's disease; and preclinical stage to treat Parkinson's disease. Its preclinical drug candidates include ANAVEX 3-71, which uses ligands that activate sigma-1 and M1 muscarinic receptors to treat Alzheimer's disease; ANAVEX 1-41, a sigma-1 agonist that protects nerve cells from degeneration or death; ANAVEX 1037 for the treatment of prostate cancer; and ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the treatment of neuropathic and visceral pain. The company was founded in 2006 and is based in New York, New York.http://www.priceseries.com/trade/AVXL-Anavex-Life-Sciences-Corp-stock-gains-41-percent-a-Trade-Record-by-priceSeries-2020020320200224.html

APTO Aptose Biosciences, Inc. gains 31% Feb 24, 2020

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, a small molecule that induces the transcription of the Kruppel-like factor 4 Gene in in vitro studies and in in vivo pharmacodynamic studies of human xenograft tumors in mice. The company's APTO-253 clinical program has completed Phase-I clinical trials for the treatment of various solid tumors; and Phase-Ib clinical trials for relapsed/refractory hematologic malignancies. It also develops APTO-500 program that focuses on discovering and developing small molecule inhibitors of maternal embryonic leucine zipper kinase; and is in a pre-clinical stage for oncology. It has a license agreement with Genentech Inc. to develop and sub-license a specified polypeptide; and collaboration agreement with Eli Lilly and Company to investigate a proprietary series of the company's compounds for veterinary medicine. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.http://www.priceseries.com/trade/APTO-Aptose-Biosciences-Inc-stock-gains-31-percent-a-Trade-Record-by-priceSeries-2020012820200224.html

AKBA Akebia Therapeutics, Inc. gains 16% Feb 24, 2020

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product candidates that include AKB-6899 for the treatment of anemia; and AKB-5169, a preclinical compound for the treatment for inflammatory bowel disease. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, as well as with Mitsubishi Tanabe Pharma Corporation for the development and commercialization to vadadustat in Japan and other Asian countries. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/AKBA-Akebia-Therapeutics-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020020320200224.html

ADVM Adverum Biotechnologies, Inc. gains 18% Feb 24, 2020

Avalanche Biotechnologies, Inc., a gene therapy company, engages in discovering and developing novel medicines that offer therapeutic benefit to patients suffering from chronic or debilitating disease. It primary focuses on developing AVA-101, which is in a Phase IIa trial for the treatment of wet age-related macular degeneration (AMD). The company is also developing AVA-201, a product candidate for the prevention of wet AMD; AVA-311 that is in preclinical studies for the treatment of juvenile X-linked retinoschisis, a rare genetic disease of the retina with no approved therapy; and AVA-322 and AVA-323 for the treatment of color vision deficiency. Avalanche Biotechnologies, Inc. has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize gene therapy products. The company was founded in 2006 and is headquartered in Menlo Park, California.http://www.priceseries.com/trade/ADVM-Adverum-Biotechnologies-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2020021020200224.html

ADRO Aduro Biotech, Inc. gains 89% Feb 24, 2020

Aduro BioTech, Inc., an immunotherapy company, focuses on the discovery, development, and commercialization that transform the treatment of challenging diseases. It is developing CRS-207, which has completed Phase Ib clinical trials for the treatment of unresectable malignant pleural mesothelioma; that has completed Phase II clinical trials for the treatment of pancreatic cancer; and that is in Phase I/II clinical trials for the treatment of ovarian cancer. The company is also developing ADU-214 that is in Phase I clinical trials for the treatment of lung cancer; ADU-741, which is in Phase I clinical trials for the treatment of prostate cancer; and a product candidate for the treatment of patients with cancers of the gastrointestinal tract. In addition, it is developing STING Pathway Activator product candidates that are synthetic small molecule immune modulators, which target and activate Stimulator of Interferon Genes receptor under collaboration with Novartis Pharmaceuticals Corporation; and product candidates that address other therapeutic areas, such as autoimmune and infectious diseases. Further, the company's products pipeline comprises BION-1301, a B-select mAb novel therapy for multiple myeloma; and antibody product candidates, including APRIL for the treatment of multiple myeloma, as well as oncology therapies, such as CD27, PD-1, and CTLA-4. Aduro BioTech, Inc. has a collaboration agreement with Janssen Biotech, Inc. to develop drugs for the treatment of prostate and lung cancers; and development and commercialization agreement with Genmab to evaluate five bispecific antibody product candidates targeting immune checkpoints. The company was formerly known as Oncologic, Inc. and changed its name to Aduro BioTech, Inc. in June 2008. Aduro BioTech, Inc. was founded in 2000 and is headquartered in Berkeley, California.http://www.priceseries.com/trade/ADRO-Aduro-Biotech-Inc-stock-gains-89-percent-a-Trade-Record-by-priceSeries-2020013120200224.html

SCO Ultrashort DJ-UBS Crude Oil gains 35% Feb 12, 2020

http://www.priceseries.com/trade/SCO-Ultrashort-DJ-UBS-Crude-Oil--stock-gains-35-percent-a-Trade-Record-by-priceSeries-2020010820200212.html

PCG Pacific Gas & Electric Co. gains 47% Feb 12, 2020

PG&E Corporation, through its subsidiary, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California. The company's electricity distribution network consists of approximately 142,000 circuit miles of distribution lines, 59 transmission switching substations, and 606 distribution substations; and electricity transmission network comprises approximately 18,400 circuit miles of interconnected transmission lines and 92 electric transmission substations. Its natural gas system consists of approximately 42,800 miles of distribution pipelines, approximately 6,700 miles of backbone and local transmission pipelines, and various storage facilities. The company operates various electricity generation facilities, such as nuclear, hydroelectric, fossil fuel-fired, and photovoltaic. PG&E Corporation was founded in 1905 and is headquartered in San Francisco, California.http://www.priceseries.com/trade/PCG-Pacific-Gas-&-Electric-Co-stock-gains-47-percent-a-Trade-Record-by-priceSeries-2020011320200212.html

CLW Clearwater Paper Corp. gains 35% Feb 12, 2020

Clearwater Paper Corporation produces and sells private label tissue and bleached paperboard products in the United States and internationally. The company operates through two segments, Consumer Products, and Pulp and Paperboard. The Consumer Products segment manufactures and sells a line of at-home tissue products, including bathroom tissues, paper towels, facial tissues, and napkins; recycled fiber value grade products; and away-from-home products, such as conventional one- and two-ply bath tissues, two-ply paper towels, hard wound towels, and dispenser napkins. This segment sells its products to retailers and wholesale distributors, including grocery, drug, mass merchants, and discount stores. The Pulp and Paperboard segment provides bleached paperboard, folding cartons, liquid packaging paperboards, cups, plates, commercial printing grades, and hardwood and softwood pulp products. It sells its products to packaging converters through sales offices; and to commercial printers through distribution. The company also provides custom sheeting, slitting, and cutting services. Clearwater Paper Corporation is headquartered in Spokane, Washington.http://www.priceseries.com/trade/CLW-Clearwater-Paper-Corp-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2020011420200212.html

RVNC Revance Therapeutics, Inc. gains 45% Feb 11, 2020

Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark, California.http://www.priceseries.com/trade/RVNC-Revance-Therapeutics-Inc-stock-gains-45-percent-a-Trade-Record-by-priceSeries-2020010720200211.html

GASX Direxion Daily Natural Gas Rela gains 55% Feb 5, 2020

http://www.priceseries.com/trade/GASX-Direxion-Daily-Natural-Gas-Rela-stock-gains-55-percent-a-Trade-Record-by-priceSeries-2020011620200205.html

ERY Energy Bear 3X Direxion gains 23% Feb 5, 2020

http://www.priceseries.com/trade/ERY-Energy-Bear-3X-Direxion-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2020011720200205.html

DUG Ultrashort Oil & Gas gains 15% Feb 5, 2020

http://www.priceseries.com/trade/DUG-Ultrashort-Oil-&-Gas--stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020011720200205.html

DRIP Direxion Daily S&P Oil & Gas Ex gains 61% Feb 5, 2020

http://www.priceseries.com/trade/DRIP-Direxion-Daily-S&P-Oil-&-Gas-Ex-stock-gains-61-percent-a-Trade-Record-by-priceSeries-2020010820200205.html

CODX Co-Diagnostics, Inc. gains 144% Feb 5, 2020

N/Ahttp://www.priceseries.com/trade/CODX-Co-Diagnostics-Inc-stock-gains-144-percent-a-Trade-Record-by-priceSeries-2020011520200205.html

AYX Alteryx, Inc. gains 27% Feb 5, 2020

N/Ahttp://www.priceseries.com/trade/AYX-Alteryx-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2020010220200205.html